Maximus (MMS) to Release Earnings on Wednesday

Maximus (NYSE:MMS) will post its quarterly earnings results after the market closes on Wednesday, May 8th. Analysts expect Maximus to post earnings of $1.30 per share for the quarter. Maximus has set its FY24 guidance at $5.20-5.50 EPS and its FY 2024 guidance at 5.200-5.500 EPS.Individual interested in listening to the company’s earnings conference call can do so using this link.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Wednesday, February 7th. The health services provider reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.06. Maximus had a return on equity of 15.68% and a net margin of 3.73%. The firm had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.29 billion. During the same period in the prior year, the business posted $0.94 earnings per share. The company’s revenue was up 6.2% on a year-over-year basis. On average, analysts expect Maximus to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Maximus Trading Down 0.9 %

Shares of MMS opened at $80.27 on Wednesday. Maximus has a twelve month low of $72.39 and a twelve month high of $89.69. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.71. The stock has a market cap of $4.90 billion, a PE ratio of 26.63 and a beta of 0.72. The business’s 50-day moving average price is $82.41 and its 200-day moving average price is $81.41.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.50%. The ex-dividend date is Tuesday, May 14th. Maximus’s payout ratio is 39.74%.

Wall Street Analyst Weigh In

MMS has been the subject of several recent analyst reports. StockNews.com raised Maximus from a “hold” rating to a “buy” rating in a report on Thursday, February 8th. Raymond James lowered Maximus from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 3rd.

Insiders Place Their Bets

In other Maximus news, CFO David Mutryn sold 8,000 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $83.95, for a total value of $671,600.00. Following the completion of the sale, the chief financial officer now owns 5,124 shares of the company’s stock, valued at $430,159.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.40% of the stock is owned by insiders.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.